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Quadrupole ion trap scanning parameters for performing bottom-up proteomics in a data-
dependent fashion were evaluated on a Finnigan LCQ Deca mass spectrometer. Evaluation of
parameters such as the number of averaged full scans, the number of averaged MS/MS scans,
and ion injection times were necessary for acquiring high quality MS/MS spectra that yield
favorable b and y ion coverage and high correlation to proteins using database searching
algorithms. In this study, we demonstrated how the duty cycle of the mass spectrometer affects
the number of peptides that can be successfully identified by SEQUEST using a model system
of tryptic BSA peptides to mimic a typical complex mixture associated with bottom-up
proteomics. The number of averaged scans and the duration of ion accumulation in the trap
had a significant effect on the quality of acquired MS/MS spectra. For example, by increasing
the ion injection time from 500 ms to 600 ms, peptide HLVDEPQNLIK improved from being
improperly identified to being correctly identified with a SEQUEST cross-correlation score of
3.60. As a result of these experiments, we have devised the following set of ion trap parameters
for performing bottom-up proteomics analysis in our laboratory: Three averaged full scans,
five averaged MS/MS scans, and a maximum ion injection time of 600 ms. (J Am Soc Mass
Spectrom 2004, 15, 150157) © 2004 American Society for Mass Spectrometry
In recent years, the bottom-up approach to proteom-ics has gained much notoriety in the scientific com-munity [1–15]. This approach begins with the pro-
teolysis of a protein or mixture of proteins to generate
an even more complex mixture of peptides. These
peptides are isolated, subjected to direct MS/MS anal-
ysis, and identified via protein database searching al-
gorithms that match the acquired MS/MS spectra to
computer-predicted spectra and lead to the identifica-
tion of the parent proteins [16, 17]. However, the
challenge of accurately identifying all proteins present
in a mixture relies on the ability to sufficiently resolve
all peptides resulting from the enzymatic digestion
while simultaneously acquiring high quality MS/MS
spectra which will lead to proper ion assignments and
protein correlations by the database searching algo-
rithm.
To address the problem of resolving such complex
mixtures of peptides, some research groups have em-
ployed multidimensional HPLC techniques [6–15, 18–
21]. In these schemes, peptides are separated by utiliz-
ing two or more of their physical properties such as
hydorophobicity, charge, and size. Moving to multiple
dimensions of separation modes increases peak capac-
ity (i.e., the maximum number of components that can
be resolved over a given separation length). An increase
in chromatographic peak capacity translates into a
greater number of peptides that can be resolved and
thus interrogated by MS/MS analysis. Multidimen-
sional separations undoubtedly have greatly increased
the number of proteins that can be identified in complex
mixtures; however, these techniques do have their
limitations, and peak capacity is still an issue.
Bottom-up proteomics on complex mixtures would
not be possible without the existence of instrument
decision-making algorithms that can automatically per-
form MS/MS experiments on precursor ions selected
from a previously acquired full scan. The use of such
algorithms is widely known as data-dependent analy-
sis. [Note: “Data-dependent” analysis is often associ-
ated with the Intelligent Data-Dependent tools of
Thermo Finnigan (San Jose, CA) instruments. This term
is analogous to SmartSelect™ (Bruker Daltonics, Inc.,
Billerica, MA) and Information Dependent Acquisition
(Applied Biosystems, Foster City, CA).] This feature
enables the instrument to make real-time decisions
concerning the experiment at hand. For example, as
peptides are eluted from an HPLC separation, the mass
spectrometer continuously acquires full scan data. Once
an ion is detected above a preset threshold, the instru-
ment automatically switches from full scan to MS/MS
mode to perform a tandem experiment on that ion. In
the event of multiple, coeluting peptides, the instru-
ment will perform a MS/MS analysis on one ion
(usually the most intense), place that ion on an exclu-
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sion list, and then continue on with its data-dependent
analysis of other ions present in the full scan. Once an
ion is subjected to MS/MS and placed on the exclusion
list, it remains there and will not be polled again for a
user-defined length of time. The time required for the
mass spectrometer to perform a cycle of one analytical
full scan followed by one analytical MS/MS scan is
dictated by the duty cycle of the instrument. For ion
trap instruments, one analytical scan can be composed
of a number of averaged scans. Averaging multiple
scans to build one analytical scan is necessary to im-
prove the ion statistics achieved by the ion trap mass
analyzer. However, increasing the number of averaged
scans reduces the duty cycle of the instrument, thus
reducing the frequency of acquiring analytical scans.
This, in turn, results in fewer MS/MS experiments that
can be conducted over a given period of time. In cases
where poor chromatographic resolution generates sev-
eral overlapping peptides, fewer analytical scans per
unit time may prevent some peptides from being sub-
jected to an MS/MS experiment. The frequency of
analytical scan acquisition is influenced by instrumental
parameters such as the number of averaged full scans,
the number of averaged MS/MS scans, and ion trap
injection time.
In our laboratory, we utilize a micro-flow liquid
chromatographic (micro-LC) system for the proteomic
analysis of digested protein mixtures. In this setup, we
utilize 320 m i.d. capillary columns and flow rates on
the order of 4 L/min. This arrangement provides us
with the reliability we need to analyze large volumes of
samples of unknown quality and/or origin. Although
micro-LC may be slightly less sensitive, its robustness
far surpasses that of nano-flow (200–300 nL/min) sys-
tems. Nano-LC setups are commonly subject to plug-
ging due to their small column and emitter inner-
diameters, making the analysis of “real world” samples
a challenge. Additionally, when dealing with nL/min
flow rates, dead volumes become a greater concern.
This issue is typically dealt with by using trapping
columns. By first loading the sample onto a trapping
column at higher flow rates (i.e., L/min regime), then
switching to nano-flow for the analytical separation,
long sample loop evacuation times are avoided. This,
however, normally requires multiple LC pumps and
valving/switching capabilities.
To perform successful bottom-up proteomics, a del-
icate balance between peak capacity, analytical scan
acquisition rate, and ion abundances must be achieved.
Ion abundance is largely dictated by the amount of
protein present in the sample. In most “real world”
samples, it is impossible to optimize the quantities of all
proteins present. Therefore, the majority of effort must
be spent optimizing peak capacity and the analytical
scan acquisition rate. As mentioned previously, great
advancements in increasing peak capacity have been
made with the development of multidimensional tech-
niques. Now we have the capability to resolve orders of
magnitude more peptides than was possible with tra-
ditional one-dimensional LC techniques. A large num-
ber of laboratories are currently using quadrupole ion
traps for proteomics research. Recently, the Proteomics
Research Group (PRG) of the Association of Biomolec-
ular Research Facilities (ABRF) conducted an open
study in which research laboratories were invited to
participate [22]. The study required the participants to
identify the sequences and phosphorylation sites of a
peptide mixture. A total of 57 different laboratories
participated in this study. Of these, 39% of the labora-
tories utilized ion trap mass analyzers, attesting to the
utility of ion traps in proteomics. However, to date,
very little consideration has been given to the optimi-
zation of ion trap parameters for proteomics applica-
tions. Parameters such as the number of averaged scans
(full scan and MS/MS) and the injection time for ion
accumulation play a critical role in achieving high
quality spectra. Simultaneous optimization of all three
elements is crucial to achieve high quality MS/MS
spectra of all peptides present in a sample. This, in turn,
will result in more accurate fragment ion assignments
by database searching algorithms leading to higher
protein correlations.
In this work, we investigate the scan parameters of
one variety of ion trap mass analyzer, the LCQ Deca.
Furthermore, we report the effects of these parameters
on the data-dependent algorithm and our ability to
analyze the maximum number of closely eluting pep-
tides. The balance between ion trap scan parameters
and the ability to maintain an analytical scan acquisi-
tion rate amenable to interrogating the maximum num-
ber of peptides are explored. We present these experi-
mental parameters and their influence on the quality of
MS/MS data.
Experimental
Materials
Bovine serum albumin (BSA), ammonium acetate
(NH4HCO3), and ammonium bicarbonate were ob-
tained from Sigma Chemical Co. (St. Louis, MO). HPLC
grade water, HPLC grade acetoniltrile (ACN), and
formic acid were purchased from Fisher Scientific (Fair
Lawn, NJ). Sequencing grade modified trypsin was a
product of Promega (Madison, WI).
Digestion of BSA
A stock solution of 2 g/L BSA was prepared in 50
mM NH4HCO3. A 50 L aliquot was removed and
mixed with 50 L of ACN to improve proteolysis [23].
Trypsin was added to a final protease-to-BSA ratio of
1:40, and the digestion mixture was incubated at 37 °C
for 24 h. The resulting digested BSA sample was used to
prepare 10-, 100-, and 1000-fold serial dilutions in water
(i.e., protein concentrations of 100, 10, and 1 ng/L,
respectively).
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Chromatography and Mass Spectrometry
Digested BSA samples were resolved on a 15 cm  320
m i.d. reverse phase capillary column. This column
was fabricated in-house and packed with 5 m Macro-
sphere 300 C18 particles (Alltech Associates, Inc., Deer-
field, IL) using a stainless steel packing cell pressurized
with helium to 1000 psi. Sample introduction and
mobile phase delivery at 4 L/min was performed by a
LC Packings Ultimate capillary LC system (San Fran-
cisco, CA) equipped with a 5-L injection loop. Mobile
phase A was water  0.1% formic acid and mobile
phase B was ACN 0.1% formic acid. A linear gradient
of 5–95% B over 55 min was employed for the separa-
tion of the BSA peptides.
Eluting peptides in the column effluent were directly
electrosprayed into a Finnigan LCQ Deca ion trap mass
spectrometer (Thermo Finnigan, San Jose, CA) for anal-
ysis. The electrospray source was given 4.5 kV of
applied voltage and 33 arbitrary units (range 0–100) of
sheath gas flow, while the inlet capillary was held at
19.5 V and 170 °C. Other mass spectrometer parameters
were as follows: tube lens offset at 15.0 V, multipole 1
offset at5.3 V, multipole 2 offset at11.0 V, intermul-
tipole lens at77.0 V, entrance lens at82.0 V and trap
DC offset at 10.0 V. Spectra of eluting BSA peptides
were acquired in a data-dependent fashion by first
acquiring a full MS scan from m/z 150 to 2000 followed
by a MS/MS scan between m/z 150 and 2000 of the most
intense ion of the previous full MS scan. MS/MS scans
were acquired using an activation qz of 0.250, activation
time of 30 ms, and 35% normalized collision energy
(NCE). (Note: NCE, is the amplitude of the resonance
excitation RF voltage scaled to the precursor mass based
on the formula: RF amplitude  [NCE%/30%] (precur-
sor ion mass  tick amp slope  tick amp intercept),
where the tick amp slope and tick amp intercept are
instrument specific values. For our LCQ Deca, 35%
NCE for m/z 1000 1.8 V.) Once sampled, each MS/MS
precursor mass was excluded from further tandem
experiments for three min. For each analytical full MS
and MS/MS scan, m number of MS scans and n number
of MS/MS scans were averaged, respectively. In these
experiments, 5-L injections of the 10-fold dilution (100
ng/L) of digested BSA were analyzed 25 times; each
time m and n were assigned a value of 1, 3, 5, 7, or 9
averaged scans until a five-by-five experimental array
had been acquired. To further refine the impact of
sample concentration on the quality of MS/MS scans,
similar experiments were performed on the 100-fold (10
ng/L) and 1000-fold (1 ng/L) dilutions of digested
BSA; however, in these cases, only 1, 5, and 9 MS and
MS/MS averaged scans were investigated to produce a
three-by-three array of data.
A flow injection experiment was also performed in
which the reverse phase capillary column was removed
and replaced with 50 m i.d. PEEK tubing. Mobile
phase (5% ACN) was delivered at 4 L/min to the
electrospray source of the mass spectrometer as before.
BSA digest (10 ng/L) was introduced into the flow in
5-L injections. As the sample plug was sprayed into
the mass spectrometer, spectra were again collected in a
data-dependent manner for a time period of one min.
For this experiment, injections were repeated in tripli-
cate for n  1, 3, 5, 7, and 9 averaged MS/MS scans,
while the number of averaged full scans was held
constant at m 3. In all experiments, the automatic gain
control (AGC) of the instrument was turned on with
target values of 5.0  107 and 2.0  107 for the MS and
MS/MS scans, respectively. For the 10-fold dilution
studies, the maximum ion injection times were set at
300 ms for the full scans and 500 ms for the MS/MS
scans. For all other experiments, the maximum MS/MS
ion injection time was increased to 600 ms.
To evaluate the quality of data acquired, the MS/MS
spectra were searched against the NCBI non-redundant
database using the SEQUEST algorithm to generate
cross-correlation scores for each peptide. However, in
each experiment, attention was only given to the spectra
acquired within a five-min window (approximately t 
21.5–26.5 min) where several peptides were coeluting.
The resulting cross-correlation scores (Xcorrs) were
subjected to criteria as set by Washburn, et al. [8]. In
short, 1, 2, and 3 charged peptides had to be
tryptic in nature and have cross-correlation scores of at
least 1.8, 2.2, and 3.75, respectively. BSA peptide corre-
lations not meeting these criteria were considered to
have ambiguous identifications.
Results and Discussion
In these experiments, we explored various ion trap
parameters (i.e., number of averaged full scans, number
of averaged MS/MS scans, and ion injection times)
capable of sampling as many poorly resolved peptides
as possible, while maintaining high quality MS/MS
spectra. A typical reverse phase separation of tryptic
BSA peptides is shown in Figure 1. shaded area denotes
the five-min time window that was considered for this
study. In this window, several peptides coeluted with
overlapping peaks. We focused only on these peptides
because we wished to mimic very complex mixtures of
peptides and to tax the instrument’s data-dependent
function.
Analysis of the 10-fold diluted BSA digest at the
various numbers of averaged scans (m and n  1, 3, 5,
7, and 9) yielded a five-by-five matrix of 25 total runs.
To understand the effect that the number of averaged
scans had on the instrument’s frequency of acquiring
analytical scans, we looked at the number of MS/MS
spectra acquired during the five-min window of inter-
est for each run (Table 1). The number of MS/MS
spectra varied from as many as 139 (m  1 full scan, n
 1 MS/MS scan) to as few as 26 (m  9 full scans, n 
9 MS/MS scans). Further investigation showed that the
average instrumental processing time required to ac-
quire one analytical full scan followed by one analytical
MS/MS scan ranged from 1.9 s (m  1 full scan, n  1
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MS/MS scan) to 15.4 s (m  9 full scans, n  9 MS/MS
scans). This illustrated how the frequency of acquiring
analytical scans affected the number of spectra that
could be acquired over a given time. As we increased
the total number of averaged scans that had to be
acquired and averaged, more time was required to
generate one analytical scan, which in turn resulted in a
fewer number MS/MS spectra that could be obtained.
For this reason, fewer number of analytical scans per
second would be undesirable in situations where sev-
eral peptides are coeluting.
To better understand the relationship between the
number of scans that were averaged and spectra qual-
ity, we performed database searches of the MS/MS
spectra acquired during the five-min window of inter-
est for all 25 combinations of averaged scans. Only
those spectra yielding unambiguous peptide matches
were considered. The numbers of unique BSA peptides
identified for each combination of averaged scans were
tabulated (Table 2). This set of experiments yielded as
few as one and as many as seven unique peptide
matches. However, when closely examined, the data
revealed an area of enriched peptide matches. This area
was bracketed by the ion trap settings of m 1 full scan,
n 3 MS/MS scans and m 5 full scans, n 9 MS/MS
scans. The runs encompassed by these settings pro-
duced mostly 5, 6, or 7 BSA peptide matches. It was also
noted that the maximum MS/MS ion injection time of
500 ms was entirely utilized for almost all of the
acquired MS/MS scans.
We then decreased the amount of injected sample by
a factor of 10 (50 ng on column) in an attempt to further
target a combination of averaged scans that would be
superior to the others in identifying the greatest number
of unique peptides. This time, however, the experimen-
tal array was reduced to nine individual runs consisting
of combinations of 1, 5, and 9 averaged scans to
Table 1. Number of MS/MS spectra acquired at various
combinations of averaged full scans and MS/MS scans.
Table 2. Number of unique peptides unambiguously identified
from 500 ng of BSA digest at various combinations of averaged
full scans and MS/MS scans.
Table 3. Number of unique peptides identified from 50 ng of
BSA digest at various combinations of averaged full scans and
MS/MS scans.
Figure 1. A chromatogram depicting a typical reverse phase
separation of BSA tryptic peptides. The shaded region represents
the five-min window of interest and contains several poorly
resolved, coeluting peptides. Only peptides eluting in this region
were evaluated in all experiments.
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expedite the experimental process. In addition, the
maximum MS/MS ion injection time was increased
from 500 ms to 600 ms. This resulted in a surprisingly
large increase of identified peptides across the board
despite the decrease in sample concentration (Table 3).
Close examination of the MS/MS spectra revealed an
overall increase in spectral quality, including increases
in total ion intensities and b and y fragment ion cover-
age. This was especially pronounced in 3 charged
peptides (Figure 2), the previously bracketed combina-
tions of averaged scans (m  1 full scan, n  3 MS/MS
to m 5 full scans, n 9 MS/MS) seemed to once again
generate higher numbers of matched peptides.
To further investigate this, a third array of experi-
ments was conducted using a 1000-fold dilution of
stock BSA digest (5 ng on column; Table 4). Again, the
array was truncated to a three-by-three scan matrix
using maximum MS/MS ion injection times of 600 ms.
Searching these acquisitions against the database pro-
duced matched peptide numbers similar to those
achieved with 500 ng of sample on column with maxi-
mum MS/MS injection times of 500 ms. Once again, an
area of enhanced peptide correlation was observed in
the upper right hand quadrant of the table as bracketed
by m  1 full scan, n  3 MS/MS scans and m  5 full
scans, n  9 MS/MS scans.
The impact that the ion injection times had on the
number of identified BSA peptides was quite remark-
able and warranted further investigation. To do this, we
held the combination of averaged full scans and
MS/MS scans at 3 and 5, respectively. Triplicate anal-
yses of the 1000-fold dilution of BSA digest were
performed at maximum ion injection times of 500, 600,
and 700 ms. To evaluate the effect that injection times
had on the quality of acquired MS/MS spectra, we
looked at the average Xcorr of four unique BSA pep-
tides (Table 5). In all cases, the MS/MS spectra acquired
with 600-ms maximum injection times provided cor-
rectly assigned peptide sequences and yielded the best
Xcorrs. Acquisitions at 500- and 700-ms maximum
injection times, however, produced statistically lower
Xcorrs and occasionally generated SEQUEST search
results that were not the proper amino acid sequences
for these peptides. Examples of MS/MS spectra ac-
quired at each ion injection time for the BSA peptide
HLVDEPQNILK are shown in Figure 3. lts indicated
that a maximum ion injection time of 500 ms was not
sufficiently long to fill the ion trap with a suitable
population of precursor ions. In this case few fragment
ions were generated, contributing to low total ion
current, thus providing poor MS/MS spectra quality.
On the other hand, 700 ms may have been too long to
accumulate ions in the trap, resulting in space charge
effects. It should be noted that, in most MS/MS scans,
all 700 ms were utilized for ion accumulation, which
may have been an indication that the AGC target value
of 2.0  107 was too high.
A flow injection experiment was performed in an
attempt to further isolate an ideal set of scan parame-
ters. Sample introduction of 10 ng/L BSA digest was
made in multiple 5-L injections. As each sample plug
was sprayed into the mass spectrometer, the instrument
acquired as many data-dependent spectra as possible in
one min, the elution time of a typical chromatographic
peak (i.e., full width at base). For each injection, the
number of full scans were held constant at m  3, while
the number of averaged MS/MS scans were set at n 
1, 3, 5, 7, or 9. Once again, this experiment illustrated
the impact that the number of averaged scans had on
the frequency of acquiring analytical MS/MS spectra.
The combination of m  three full scans and n  1
MS/MS scan produced an average of 24.7  0.6 analyt-
ical MS/MS scan attempts during the one-min time
period, while n 9 MS/MS scans yielded only 9.3 0.6
attempted analytical MS/MS spectra. The quality of
these spectra was exhibited in the number of BSA
peptides that were identified during the 1-min acquisi-
tion time. On average, only 1.0 0.0 BSA peptides were
identified with m 3 full scans and n 1 MS/MS scan,
whereas 3.3  0.6 peptides were identified using n  9
MS/MS scans. Once again, this demonstrated how the
ion statistics were improved by averaging more scans,
leading to higher quality spectra. Closer inspection of
Figure 2. MS/MS spectra of BSA peptide KVPQVSTPTLVEVSR
(3) at 547.7 m/z. (a) 500 ng of BSA digest with a maximum ion
injection time of 500 ms. (b) 50 ng of BSA digest with a maximum
ion injection time of 600 ms.
Table 4. Number of unique peptides identified from 5 ng of
BSA digest at various combinations of averaged full scans and
MS/MS scans.
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the data showed that one or three averaged MS/MS
scans produced insufficient spectra quality and led to
the identification of 1 BSA peptide on average. The
greatest enhancement in spectra quality was achieved
by increasing the number of averaged MS/MS scans
from 3 to 5, with more subtle increases in quality from
5 to 7 and 7 to 9 averaged MS/MS scans. However, by
plotting the number of attempted analytical MS/MS
spectra and the number of identified BSA peptides both
as a function of averaged MS/MS scans on the same
graph (Figure 4e), relationship between the number of
acquired MS/MS spectra and spectrum quality became
Table 5. Average cross-correlation scores of four unique BSA peptides using 500, 600, and 700-ms MS/MS maximum ion injection
times
AEFVEVTK (1) LVTDLTK (1) HLVDEPQNLIK (2)
KVPVQVSTPT
LVEVSR (2)
500 ms 1.870.06† 1.520.18† N/A* N/A*
600 ms 2.180.19† 1.670.10† 3.370.24† 3.700.49†
700 ms 1.530.34† N/A* 2.800.09† 2.970.46†
*N/A  peptide was not correctly identified in all replicates.
†Relative standard deviation.
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Figure 3. SEQUEST b and y ion assignments for MS/MS spectra of BSA peptide HLVDEPQNLIK
(2). (a) Spectrum acquired with 500-ms maximum ion injection time. (b) Spectrum acquired with
600-ms maximum ion injection time. (c) Spectrum acquired with 700-ms maximum ion injection time.
*N/A  amino acid sequence incorrectly identified.
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apparent. Although nine averaged MS/MS scans
yielded the greatest number of identified peptides, the
time required to assemble one analytical MS/MS spec-
trum was too long for a typical proteomics analysis of a
complex mixture of peptides and would result in miss-
ing some coeluting peptides. It became evident that a
compromise must be made between the frequency of
acquiring analytical MS/MS scans and spectrum qual-
ity. The combination of m  3 full scans and n  5
MS/MS scans seemed to be the logical choice. The 5
averaged MS/MS scans produced spectra that were far
superior to that of one or three averaged MS/MS scans
while requiring less acquisition time than nine averaged
MS/MS scans. One may argue that seven averaged
MS/MS scans are even better than 5, but upon inspec-
tion of the their respective number of BSA peptides that
were cumulatively identified from the three replicate
flow injection runs, only one more peptide was identi-
fied using seven averaged MS/MS scans than was
identified using 5 averaged scans. In light of the need
for high spectrum acquisition frequency, this was not a
significant enhancement.
These experiments revealed the complexity of opti-
mizing ion trap parameters for the purpose of perform-
ing bottom-up proteomics in a data-dependent fashion.
It was obvious that one element to achieving high
quality MS/MS spectra was the ion abundance in the
trap, as was indicated by the ion injection time experi-
ments. Adding to this complexity was the dynamic ion
abundance across an eluting peptide peak. The location
on the peak at which an MS/MS was performed greatly
affected the quality of the MS/MS spectrum and the
resulting Xcorr (Figure 5). It would have been desirable
to acquire an MS/MS spectrum of an eluting peptide at
the apex of its chromatographic peak since this would
provide the highest abundance of precursor ions in the
trap, thus the highest possible quality of spectrum.
Unfortunately, there is currently no way to accomplish
this feat.
Conclusions
In this paper, we describe a range of ion trap parame-
ters for the Finnigan LCQ Deca ion trap mass spectrom-
eter to enhance the ability to acquire high quality
MS/MS spectra for the purpose of proteomics. We have
illustrated how achieving high quality spectra requires
the simultaneous cooperation of several dynamic ele-
ments, including peak capacity, analytical scan acquisi-
tion rate, and ion abundance. For example, we have
shown how decreasing the number of analytical scans
per s by averaging more scans reduces the number of
spectra that can be acquired over a given time. How-
ever, to achieve high quality spectra amenable to un-
ambiguous peptide correlations, we must average at
least m  1 full scan and n  3 MS/MS scans. On the
other hand, when dealing with very complex mixtures
of peptides that may generate poorly resolved or coe-
luting chromatographic peaks, we have determined
that no more than 5 full scans and 9 MS/MS scans
should be averaged. Beyond this, spectrum quality is
not necessarily increased, but rather the rate of acquir-
ing analytical scans becomes too slow and some eluting
peptides are not polled. We have also shown that by
changing the maximum ion injection time from 500 ms
to 600 ms, the quality of MS/MS spectra is greatly
increased, leading to better peptide correlations.
In conclusion, we have determined that to identify a
unique set of ion trap parameters applicable to pro-
teomics LC/MS/MS experiments, a compromise must
be made between the acquisition frequency of analytical
scans and the resulting quality of the MS/MS spectra.
For most data-dependent proteomics experiments, we
have shown that the following rule of thumb would
apply: 3 averaged full scans, 5 averaged MS/MS scans,
and a maximum ion injection time of 600 ms. These
settings produce MS/MS spectra among the highest
possible quality while still maintaining a rate of spec-
trum acquisition that is capable of analyzing all eluting
peptides in complex mixture.
Figure 4. A graph depicting the results of the flow injection
experiment using 5 L injections of 10 ng/L BSA digest. Spectra
were acquired in a data-dependent manner for one min. The
graph shows the number of analytical MS/MS spectra that were
attempted (filled square) and the number of identified BSA
peptides (filled triangle) as a function of the number of averaged
MS/MS scans.
Figure 5. Cross-correlation scores for BSA peptide
KVPQVSTPTLVEVSR (2), 880.8 m/z. MS/MS spectra were ob-
tained at the denoted locations on the chromatographic peak and
subjected to a protein database search with SEQUEST.
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